“…Abnormal level of release NETs can be associated with the pathogenesis of different disorders, including lung injury [19,21] , nephritis [22] , cardiovascular disease [23] , autoimmune disorders (e.g., rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome [18,22] ), as well as lung, breast or pancreatic cancer progression [24,25] . In the tumor microenvironment, the activity of release NE from NETs may also correlate with the formation of breast or colorectal cancer metastases [26,27] . Additionally, recent studies confirm that it is also related to COVID-19 due to SARS-CoV-2 infection can directly induce the increased formation of NETs in neutrophils [28][29][30] .…”